Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Rivus posts a win for its experimental obesity drug in heart failure patients
9 months ago
R&D
Federal judge rules against Novartis in Entresto generic lawsuit
9 months ago
Pharma
FDA+
IRA price negotiation results to be released Thursday — report
9 months ago
Pharma
Law
Kyverna shares safety data for CAR-T; Evotec gets $75M milestone
9 months ago
News Briefing
CSL Behring says uptake of hemophilia B gene therapy slower than expected
9 months ago
Pharma
Cell/Gene Tx
Galderma wins FDA approval for IL-31 drug in chronic skin disease
9 months ago
Pharma
FDA+
Exclusive: Gates Foundation backs startup using optogenetics to manufacture biologics
9 months ago
Financing
R&D
Why a new health tech venture firm is investing only in founders with a healthcare background
9 months ago
Financing
Health Tech
Lawmakers renew calls for government to finalize march-in guidance
9 months ago
Pharma
FDA+
J&J receives support for $6.5B talc settlement — report
9 months ago
Pharma
Law
Pressure from anti-China legislation begins to ripple through biopharma
9 months ago
China
Pharma
Legend continues Carvykti factory builds to cement CAR-T territory with J&J
9 months ago
Pharma
Cell/Gene Tx
Revance to be acquired for $900M+ as Botox trade secrets lawsuit continues
9 months ago
Deals
Corrected: Novo Nordisk to file in EU and China with late-phase insulin plus semaglutide data – but not yet in the ...
9 months ago
R&D
FDA+
Three papers on MDMA are retracted by medical journal, just a day after Lykos' FDA rejection
9 months ago
R&D
Pharma
Tenax raises $100M; Sanofi buys into MeiraGTx
9 months ago
News Briefing
Ascendis scores FDA approval for hypoparathyroidism candidate to replace Takeda's pulled drug
9 months ago
Pharma
FDA+
Pfizer touts strength of RSV vaccine in subgroup of younger immunocompromised patients
9 months ago
R&D
Pharma
Halda adds $126M to test oral drugs for prostate, breast cancer
9 months ago
Financing
Startups
FDA delays approval decision on Humacyte’s lab-grown blood vessels
9 months ago
FDA+
Latest on MDMA rejection; Novo vs. Lilly earnings; Recursion, Exscientia to merge; Q&A with Genentech CEO; and more
9 months ago
Weekly
Lykos’ MDMA-assisted PTSD treatment rejected by FDA after troubled trial and pushback from experts
9 months ago
Pharma
FDA+
Ohio federal judge dismisses IRA suit brought by US Chamber of Commerce
9 months ago
Pharma
Law
Amgen announces plans for new site in India to strengthen AI, data and life sciences
9 months ago
R&D
Pharma
First page
Previous page
109
110
111
112
113
114
115
Next page
Last page